Skip to main content
Premium Trial:

Request an Annual Quote

Enzo Offers Shares to Lawyers to Pay Legal Fees

NEW YORK (GenomeWeb News) – Enzo Biochem has issued 275,000 shares of its common stock to its law firm as payment for legal fees, the New York-based company disclosed in a document filed on Friday with the US Securities and Exchange Commission.

In its SEC document Enzo said that the offering, which closed on June 27, was made to pay $500,000 it owed its legal counsel Greenberg Traurig. Based on the $1.73 closing price of Enzo's stock on June 26, the aggregate value of the shares issued in the offering was $475,750, Enzo said.

Last month, the company said that third-quarter revenues were flat year-over-year at $25.9 million, while net loss widened to $3.4 million, or $.09 per share.

In afternoon trading, shares of Enzo on the New York Stock Exchange,were down 2 percent to $1.64.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.